raremaprare-disease reference indexOrphadata 2026-06-23 · HPO 2026-09-01
ORPHA:99014

X-linked Charcot-Marie-Tooth disease type 5

Synonyms: CMT5X · CMTX5

Type
Disease
Group
Disorder
Inheritance
X-linked recessive
Age of onset
Childhood, Infancy
Status
active

A rare genetic peripheral sensorimotor neuropathy characterized by infancy-to childhood onset of progressive distal muscle weakness and atrophy (first appearing and more prominent in the lower extremities than the upper) which usually manifests with foot drop and gait disturbance, bilateral, profound, prelingual sensorineural hearing loss and progressive optic neuropathy.

1

Names in Orphadata languages

12 of 12 languages
LangNameSynonyms
enX-linked Charcot-Marie-Tooth disease type 5CMT5X · CMTX5
frMaladie de Charcot-Marie-Tooth liée à l'X type 5= en
deCharcot-Marie-Tooth-Krankheit, X-chromosomale, Typ 5CMT5X
esEnfermedad de Charcot-Marie-Tooth ligada al cromosoma X tipo 5= en
itMalattia di Charcot-Marie-Tooth legata all'X, tipo 5= en
nlX-gebonden ziekte van Charcot-Marie-Tooth type 5= en
ptDoença de Charcot-Marie-Tooth ligada ao X tipo 5= en
plChoroba Charcota, Mariego i Tootha typu 5 sprzężona z chromosomem X= en
csX-vázaná Charcotova-Marieova-Toothova nemoc, typ 5CMT5X · CMTX5 · X-vázaná Charcot-Marie-Toothova nemoc, typ 5
ukХ-зчеплена хвороба Шарко-Марі-Тута, тип 5= en
zhX-连锁腓骨肌萎缩症5型CMTX5
trX'e bağlı Charcot-Marie-Tooth hastalığı tip 5= en

Definition in:

2

Cross-references

qualifier = Orphanet mapping relation
SourceCodeQualifierICD relationValidation
OMIM311070Evalidated
ICD-10G60.0NTBTattributedvalidated
ICD-11LD90.YNTBTindexvalidated
MONDO0010699Evalidated
UMLSC1839566Evalidated
GARD114Evalidated

E exact · NTBT this ORPHAcode is narrower than the target · BTNT broader than the target · ND not decided.

3

Classification

Preferential parent (Orphanet linearisation):

Parents in the classifications (4):

No children.

4

Genes

1 direct
GeneAssociationStatusHGNCEnsemblOMIMLocusNameSource of validation
PRPS1Disease-causing germline mutation(s) inAssessedHGNC:9462ENSG00000147224311850Xq22.3phosphoribosyl pyrophosphate synthetase 120301731[PMID]
5

Prevalence and incidence

2 records
TypeClassValueAreaQualificationValidationSource
Point prevalence<1 / 1 000 000—WorldwideClass onlyValidatedORPHANET_17701900[PMID]_20301731[PMID]
Cases/families9 casesWorldwideCase(s)Validated17701900[PMID]_20301731[PMID]

Value is Orphadata's ValMoy: the mean estimate per 100 000 for prevalence and incidence, the number of cases or families for case reports.

6

HPO phenotypes

19 annotations · validated 2016-06-01
HPOTerm (as annotated by Orphanet)Diagnostic
Very frequent (99-80%)
HP:0040129Abnormal nerve conduction velocity
HP:0001284Areflexia
HP:0000365Hearing impairment
HP:0001324Muscle weakness
HP:0000648Optic atrophy
HP:0009830Peripheral neuropathy
HP:0001761Pes cavus
HP:0000763Sensory neuropathy
HP:0003712Skeletal muscle hypertrophy
Frequent (79-30%)
HP:0007328Impaired pain sensation
Occasional (29-5%)
HP:0001251Ataxia
HP:0001260Dysarthria
HP:0001262Excessive daytime somnolence
HP:0001288Gait disturbance
HP:0002808Kyphosis
HP:0002463Language impairment
HP:0002385Paraparesis
HP:0002650Scoliosis
HP:0001337Tremor

Run the differential on the 9 obligate / very frequent terms

Annotation source: 20301731[PMID]

7

Sources for this card